ANSYS - FDA - Avicenna
Roundtable Discussion

SAVE THE DATE! Roundtable discussion in Washington on 11 October 2019

 

For those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?". 

 

The goal of the meeting is to discuss opportunities and challenges when utilizing in silico approaches during development and regulatory review.  The event will be organized around 2 panel discussions, where senior leaders from the largest medical device and pharmaceutical companies will be sharing their experience and expectations.

When and where: 11 October 2019, Marriott at Hyattsville Maryland (same hotel as BMES Conference).

 

Please register here to reserve your spot.

Do not hesitate to contact Krista Loeffler at krista.loeffler@ansys.com for more information.

 

The draft agenda is structured as follows:

Avicenna Alliance news

Avicenna present at the European Research & Innovation Days

The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses,...

find out more ›

SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the...

find out more ›

Avicenna answers online consultation to shape Horizon Europe

On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework...

find out more ›

Prestigious FDA award allocated to group that developed the V&V 40 standard

The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up